• Company
• The number of reimbursed drugs is the lowest in 33 months
• by Chon, Seung-Hyun Nov 9, 2022 05:47am

• Policy
• Drug prices should be raised if RWD show high effect
• by Lee, Tak-Sun Nov 9, 2022 05:47am

• Company
• Atozet market ↑40% in 1 year...Lipitor Plus leads generics
• by Kim, Jin-Gu Nov 9, 2022 05:47am

• Company
• SGLT-2 diabetes medication is on the rise
• by Kim, Jin-Gu Nov 8, 2022 05:43am

• Policy
• Ex officio adjustment reduces prices of Faslodex and Acelex
• by Kim, Jung-Ju Nov 8, 2022 05:43am

• Fenofibrate 145mg available for an empty stomach
• by Lee, Tak-Sun Nov 7, 2022 06:06am

• Company
• 2 new myelofibrosis drugs fail to extend coverage
• by Eo, Yun-Ho Nov 7, 2022 06:06am

• Policy
• It has been four years since Eucept was released
• by Lee, Hye-Kyung Nov 7, 2022 06:06am

• Policy
• We will continue to strengthen cooperation with the HIRA
• by Kim, Jung-Ju Nov 7, 2022 06:05am

• Policy
• No budget set to compensate increasing Paxlovid AE reports
• by Lee, Jeong-Hwan Nov 7, 2022 06:05am